Fallbrook, CA, United States of America

W Brad Wan

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 5.2

ph-index = 3

Forward Citations = 14(Granted Patents)


Company Filing History:


Years Active: 2017-2020

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: W Brad Wan: Innovator in Reactive Conjugate Clusters and Oligomeric Compounds

Introduction

W Brad Wan is a notable inventor based in Fallbrook, CA (US), recognized for his contributions to the field of chemistry and pharmaceuticals. He holds a total of 5 patents, showcasing his innovative approach to complex chemical synthesis and compound development.

Latest Patents

One of his latest patents is titled "Method for synthesis of reactive conjugate clusters." This invention provides improved methods for synthesizing reactive conjugate clusters and the intermediates used in such methods. The enhancements reduce the number of synthetic steps required, leading to a more efficient process. The reactive conjugate clusters produced using these improved methods are free from transacylation impurities that often arise in existing methods. Additionally, these methods yield a higher overall output and offer cost benefits compared to traditional approaches.

Another significant patent is "Linkage modified oligomeric compounds." This invention presents oligomeric compounds that include at least one neutral methoxypropyl phosphonate modified internucleoside linkage. These compounds exhibit improved properties such as selectivity, potency, and a better toxicity profile. They also demonstrate enhanced stability when exposed to base during synthesis. Certain embodiments of these compounds are particularly useful for hybridizing to complementary nucleic acids, which can modulate the activity or expression of target nucleic acids within a cell.

Career Highlights

W Brad Wan is currently associated with Ionis Pharmaceuticals, Inc., where he continues to push the boundaries of pharmaceutical innovation. His work focuses on developing novel compounds that can significantly impact therapeutic applications.

Collaborations

Throughout his career, W Brad Wan has collaborated with esteemed colleagues, including Michael T Migawa and Punit P Seth. These collaborations have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

W Brad Wan's innovative work in the synthesis of reactive conjugate clusters and oligomeric compounds highlights his significant contributions to the field of chemistry and pharmaceuticals. His patents reflect a commitment to improving existing methods and developing new solutions that can enhance therapeutic efficacy.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…